O

    OraSure Technologies Inc (OSUR)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $3.59
    -0.01 (-0.28%)

    Market Cap: $248.29M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    65%(26/40)
    Avg Surprise
    +44.64%

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.18
    Range$-0.18 - $-0.18
    1 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate Drift
    90d ago$-0.13+27.0%
    60d ago$-0.15+18.7%
    30d ago$-0.15+18.7%
    7d ago$-0.15+18.7%
    Current$-0.18
    Revenue Consensus
    $31M
    Range$31M - $31M
    1 analysts
    Dec 31, 2026
    EPS Consensus$-0.23
    Range$-0.23 - $-0.23
    1 analysts
    Revenue Consensus
    $34M
    Range$34M - $34M
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.23---
    Sep 26EST
    		-$-0.18---
    Jun 26
    		$-0.23$-0.22-4.55%Miss-21.1%
    Mar 26
    		$-0.24$-0.17-41.18%Miss-33.3%
    Dec 25
    		$-0.19$-0.19+0.00%Beat-216.7%
    Sep 25
    		$-0.17$-0.20+15.00%Beat-1600.0%
    Jun 25
    		$-0.19$-0.15-26.67%Miss-371.4%
    Mar 25
    		$-0.18$-0.12-50.00%Miss-550.0%
    Dec 24
    		$-0.06$-0.01-460.75%Miss-122.2%
    Sep 24
    		$-0.01$-0.02+50.00%Beat-103.7%
    Jun 24
    		$0.07$0.03+133.33%Beat-22.2%
    Mar 24
    		$0.04$0.03+33.33%Beat-91.5%
    Dec 23
    		$0.27$0.09+200.00%Beat-25.0%
    Sep 23
    		$0.27$0.08+237.50%Beat+107.7%
    Jun 23
    		$0.09$-0.08+212.50%Beat+325.0%
    Mar 23
    		$0.47$0.14+235.71%Beat+267.9%
    Dec 22
    		$0.36$0.04+800.00%Beat+357.1%
    Sep 22
    		$0.13$0.03+333.33%Beat+159.1%
    Jun 22
    		$-0.04N/A+63.64%Beat-100.0%
    Mar 22
    		$-0.28$-0.13-115.38%Miss-660.0%
    Dec 21
    		$-0.14$-0.13-7.69%Miss-566.7%
    Sep 21
    		$-0.22$-0.05-340.00%Miss-2300.0%
    Jun 21
    		$-0.02$0.04-150.00%Miss+88.2%
    Mar 21
    		$0.05$0.03+66.67%Beat+150.0%
    Dec 20
    		$0.03N/A-57.14%Miss-50.0%
    Sep 20
    		$0.01N/A+116.67%Beat-66.7%
    Jun 20
    		$-0.17$-0.07-142.86%Miss-342.9%
    Mar 20
    		$-0.10$-0.05-100.00%Miss-400.0%
    Dec 19
    		$0.06$0.07-14.29%Miss-70.0%
    Sep 19
    		$0.03N/A-76.92%Miss-76.9%
    Jun 19
    		$0.07$0.03+133.33%Beat-36.4%
    Mar 19
    		$-0.02N/A+66.67%Beat-128.6%
    Dec 18
    		$0.20$0.11+81.82%Beat+66.7%
    Sep 18
    		$0.13$0.11+18.18%Beat+44.4%
    Jun 18
    		$0.11$0.07+57.14%Beat+22.2%
    Mar 18
    		$0.07$0.05+40.00%Beat+40.0%
    Dec 17
    		$0.12$0.11+9.09%Beat-7.7%
    Sep 17
    		$0.09$0.09+0.00%Beat-18.2%
    Jun 17
    		$0.09$0.07+28.57%Beat-
    Mar 17
    		$0.05$-0.03+266.67%Beat-
    Dec 16
    		$0.13$0.06+116.67%Beat-
    Sep 16
    		$0.11$0.07+57.14%Beat-

    Key Metrics

    Valuation
    P/E Ratio-4.33EV/EBITDA2.22x
    Price/FCF-5.15xFCF Yield-19.40%
    Profitability
    Profit Margin-43.70%Operating Margin-56.00%
    ROE-14.10%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio8.88xQuick Ratio7.68x
    Trading Statistics
    Beta1.01Avg Volume460.65K
    52-Week High$4.5852-Week Low$2.08

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$3.73
    SMA 20$3.85
    SMA 50$4.04
    SMA 200$3.23
    EMA 10$3.72
    EMA 20$3.81
    EMA 50$3.88
    EMA 200$3.48

    MACD

    Line: -0.10Signal: -0.08Hist: -0.02

    ADX

    ADX: 23.8+DI: 13.2-DI: 26.6

    Aroon & PSAR

    Aroon Up32.0
    Aroon Down100.0
    PSAR$4.03

    Bollinger Bands

    Upper Band$4.19
    Lower Band$3.51
    %B Position1762%(Upper)
    Band Width0.12

    RSI (14-Day)

    Neutral
    36.2

    Momentum Oscillators

    Stoch %K7.6
    Stoch %D10.4
    Williams %R-90.2
    ROC (10d)-5.8%
    Momentum-0.22
    CCI (20d)-131.8
    MFI (14d)29.8

    Volatility Measures

    ATR (14d)$0.15(4.3%)
    StdDev (20d)0.17
    Hist Vol41.8%(High)

    Volume Flow

    VWAP$3.59
    OBV3.1M
    AD Line-12.3M
    CMF (20d)-0.090

    Volume Metrics

    Avg Vol (20d)460.0K
    Vol Ratio0.7x
    VWMA (20d)$3.86

    Pivot Points

    R3$3.84
    R2$3.79
    R1$3.69
    Pivot Point$3.64
    S1$3.54
    S2$3.49
    S3$3.39

    Advanced Oscillators

    TSI-18.27
    Ultimate Osc43.4
    KST-84.57

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$30.64M$27.93M$26.76M$27.09M$31.24M$29.93M$37.45M$39.91M$54.34M$54.13M$75.88M$89.19M
    Cost of Revenue$17.32M$16.12M$15.79M$15.31M$18.08M$17.63M$23.88M$22.84M$29.65M$30.07M$40.76M$44.85M
    Gross Profit$13.32M$11.80M$10.97M$11.77M$13.16M$12.30M$13.57M$17.07M$24.69M$24.07M$35.13M$44.34M
    Operating Expenses$7.88M$35.07M$31.07M$27.86M$31.18M$30.05M$25.98M$23.07M$27.43M$31.16M$31.23M$33.45M
    R&D$9.44M$13.65M$11.42M$10.11M$11.40M$9.60M$6.09M$5.62M$6.60M$7.74M$6.99M$8.52M
    SG&A$14.43M$14.56M$9.82M$11.08M$12.68M$14.10M$12.90M$9.83M$11.85M$11.63M$14.01M$10.05M
    Operating Income$5.44M$-23,269,000$-20,103,000$-16,090,000$-18,026,000$-17,750,000$-12,418,000$-5,999,000$-2,740,000$-7,093,000$3.90M$10.89M
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$6.82M$-21,721,000$-18,432,000$-13,291,000$-16,891,000$-15,972,000$-9,507,000$-3,218,000$326,000$-3,602,000$20.72M$13.51M
    Income Tax Expense$55,000$-432,000$210,000$47,000$2.00M$-456,000$758,000$678,000$381,000$-18,000$647,000$2.35M
    Net Income$6.25M$-22,377,000$-19,286,000$-13,712,000$-19,693,000$-16,040,000$-10,794,000$-4,507,000$-615,000$-3,584,000$20.07M$11.16M
    EBITDA$6.35M$-19,462,000$-16,030,000$-10,910,000$-17,360,000$-13,201,000$-7,010,000$-650,000$2.84M$-871,000$24.28M$16.87M
    EBIT$6.82M$-21,721,000$-18,432,000$-13,291,000$-16,891,000$-15,972,000$-9,507,000$-3,218,000$326,000$-3,602,000$20.72M$13.51M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about OSUR

    Government Contracts

    Gov Obligations (TTM)
    $387972
    Gov Obligations / Revenue
    0.3%
    Obligations YoY
    N/A
    Active Awards
    14
    New Awards (TTM)
    0
    Avg Remaining Term
    10.2 mo

    Top agency: Department of Health and Human Services at 100.0% of trailing twelve month obligations across 1 agencies

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    3,613,836 Shares in OraSure Technologies, Inc. $OSUR Acquired by Altai Capital Management L.P.

    Altai Capital Management L.P. has acquired 3,613,836 shares of OraSure Technologies, Inc. ($OSUR), valued at approximately $16.1 million, making it their second-largest holding and representing 5.24% of the company. Institutional investors now own about 93.5% of OSUR, despite analysts maintaining a "Reduce" rating and a $3.00 price target for the stock. OraSure Technologies specializes in diagnostic and medical device products, including the OraQuick rapid HIV test.

    MarketBeat•8/25/26•
    Neutral

    Earnings Preview: OSUR to Report Financial Results Post-market on August 05

    This article announces that OSUR is scheduled to report its financial results after the market closes on August 5th. It serves as an earnings preview, alerting investors and stakeholders to the upcoming release of the company's financial performance data.

    Moomoo•8/20/26•
    Neutral

    OraSure Technologies (NASDAQ:OSUR) Gains FDA Nod for Rapid Antigen Test

    OraSure Technologies (NASDAQ:OSUR) recently received FDA authorization for a rapid antigen test and a urine-collection sample kit, expanding its reach in at-home diagnostic testing. This development highlights the company's focus on non-invasive sampling and accessible diagnostics, positioning it well within the growing trend of decentralized healthcare. OraSure's debt-free status also provides financial resilience in a dynamic market environment.

    Kalkine Media•8/16/26•
    Bullish

    OraSure Technologies(OSUR) Stock Options Chain | Quotes & News

    This article provides access to the stock options chain, quotes, and news for OraSure Technologies (OSUR). It likely includes financial data and relevant information for investors interested in the company's stock and options.

    Moomoo•8/14/26•
    Neutral

    OraSure (OSUR) Q2 2026 Earnings Call Transcript

    OraSure Technologies (OSUR) reported Q2 2026 earnings, exceeding revenue guidance with $30.6 million and showing sequential growth in Diagnostics and Sample Management Solutions. The company highlighted FDA clearances for the Colli-Pee urine collection kit and Emergency Use Authorization for the OraQuick Ebola 2.0 test, underscoring its decentralized diagnostics strategy. While the FDA submission for the IntelliQ CT/NG test was withdrawn for resubmission, management reiterated its commitment to 2026 revenue growth and achieving operating cash flow breakeven by early 2027.

    The Globe and Mail•8/13/26•
    Neutral

    Frequently Asked Questions About OSUR

    Does OSUR pay dividends?
    OraSure Technologies Inc (OSUR) does not currently pay a regular dividend.
    What is OSUR's market cap?
    OraSure Technologies Inc (OSUR) has a market capitalization of $248.29M with a current stock price of $3.59.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In